| May 29, 2008
- at the O.C. Airport
Doubletree
NOTE: Meeting
will start earlier than usual - Reception begins at 6:00 pm.
6:00 pm: Welcome
Reception
7:00 pm: Dinner
& Speaker
|
|
Meeting
Fees
|
No
charge to:
Members (in good standing)
Residents |
$30
Fee to:
Senior Members
Health Professionals
Spouse/Guests
Out of Area Doctors |
 |
Orange
County Non-Members:
click for Membership
Information |
|
| At
the conclusion of this activity, the participant will
be able to: |
| 1) |
Describe
the need for improved therapeutic strategies for patients
with advanced prostate cancer. |
| 2) |
Discuss
the latest data from the 2008 AUA Annual meeting. |
| 3) |
Identify
key barriers to treatment for minotiry or under represented
populations. |
| 4) |
Detail data on new prostatic value of PSA kinetics in
the management of Prostate Cancer. |
| 5) |
Assess emerging concepts and strategies in the management
of Prostate Cancer. |
Laurence
Klotz, MD, FRCSC(C)
Associate Professor, Division of Urology, University of Toronto
Advisory Boards:
Chair, Prostate Cancer Research Foundation of Canada Scientific
and Medical Advisory Committee
Awards/Recognitions:
Co-Investigator, Five-year inter-institutional prostate cancer
network grant by the Canadian Prostate Cancer Research Initiative
(NCIC)
Clinical Trials/Research:
Control of prostate growth and mechanisms of hormone resistance
and programmed cell death.
Neoadjuvant Cyproterone Acetate prior to prostatectomy vs
radical prostatectomy alone in patients with clinically localized
prostate cancer.
Nerve stimuation and tumescence monitoring to guide surgery.
Research suggesting 1 in 5 men with prostate cancer could
avoid treatment altogether without suffering any negative
health consequences (based on non-aggressive forms of cancer).
Editorial Boards:
Founding Editor in Chief, Canadian Journal of Urology
Managing Editor in Urology Section fo the Internal Medicine
Journal of eMedicine.com
Education/Training:
MD, University of Toronto (1977)
Residency: University of Toronto Gallie Program in Surgery
(1983)
Fellowship Memorial Sloan-Kettering Cancer Center (1985),
Special Fellow in Uro-Oncology and Tumor Biology
Preferred Talk Topics:
Hormone Therapy for Advanced Prostate Cancer
Treatment of Advanced Prostate Cancer
Evaluation and Treatment of Metastatic Bone Disease
LHRH Agonists in the Management of Advanced Prostate Cancer
Prostate Cancer: Detection, Staging, and Treatment Options
Presentations:
"CUOG/Global COOP GU", Cooperative Group Clinical
Trials: GU Oncology, 1st Annual Meeting in Urologic Oncology,
Dec. 2000
Professional Duties:
Professor, Department of Surgery, University of Toronto
Chief, Division of Urology, Sunnybrook Health Sciences Center
Past Chair, Canadian Uro-Oncology Group (CUOG) and NCIC GU
Site Group
Chair, Global GU Oncology Group
Chair, Canadian Urology Research Consortium
Chair, Prostate Cancer Research Foundation of Canada
Professional Memberships:
CUOG Executive Committee, Chairman
Canadian Medical Association
Canadian Urological Association
Member of Ontario Medical Association
Member, American Society of Urological Oncology
Member, American Urologic Association
Royal College of Surgeons of Canada
Publications/Books:
Klotz L, et al. Prostate Cancer and Erectile Dysfunction:
Men's Experiences. International Journal of Men's Health,
Vol. 1, Num. 1, Jan. 2002.
Fleshner
N, Rakovitch E, Klotz L. Differences between urologists in
the United States and Canada in the approach to prostate cancer.
J Urol. 2000;163(5):1461-1466.
Klotz L, Gleave M, Goldenberg SL. Neoadjuvant hormone therapy:
the Canadian trials. Mol Urol. 2000;4(3):233-238.
Bruchovsky N, Klotz LH, Sadar M, et al. Intermittent androgen
suppression for prostate cancer: Canadian prospective trial
and related observations. Mol Urol. 2000;4(3):191-200.
Klotz L, Heaton J, Jewett M, et al. A randomized phase 3 study
of intraoperative cavernous nerve stimulation with penile
tumescence monitoring to improve nerve sparing during radical
prostatectomy. J Urol. 2000;164(5):1573-1578.
Klotz LH. Educational research in urology. Can J Urol. 1999;6(3):764.
|
